Briacell Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$3.24

+0.14 (+4.52%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +663.9% upside

Low Target $18.09

Average Target $24.75

High Target $34.06

Current Price $3.24

Current
$3.24

Target
$24.75

$18.09 $24.75 avg $34.06

Scenario Analysis

Bear Case

$18.09

458.3%

Low target

Base Case

$24.75

+663.9%

Avg target

Bull Case

$34.06

+951.2%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$42.30

-92.3% from high

52-Week Low

$3.68

+-12.0% from low

Target vs 52W High

$24.75

-41.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%